Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideIDXXIdexx Laboratories
FinDog View：Bullish
UNHUnitedHealth Group
FinDog View：Bullish
| Metric | IDXX | UNH |
|---|
| Close | 551.21 | 406.97 |
| Market Cap | $43.9B | $367B |
| 1M | +5.56% | +10.87% |
| P/E (TTM) | 38.9 | 23.0 |
| Forward P/E | 32.2 | 17.1 |
| P/E 5-Yr Percentile | 7 | 44 |
| P/S | 9.8 | 0.8 |
| P/B | 27.5 | 3.5 |
| Dividend Yield | — | 1.37% |
| Latest Quarter Revenue | $1.2B | $112B |
| Revenue YoY | +9.7% | +0.4% |
| Gross Margin | 64.0% | 88.1% |
| Latest Quarter EPS | 4.27 | 6.04 |
| Avg Post-Earnings Move | ±1.8% | ±3.1% |
| EPS Beat Rate | — | 1 / 1 |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.68% | 2.65% |
| 90-Day Net Insider Buying | −$1.2M | −$0.66M |
IDXX · Revenue, Last 8 Quarters ($B)
UNH · Revenue, Last 8 Quarters ($B)
